Is lateral epicondylitis a new indication for botulinum toxin?
Buchbinder
Rachelle
R
Monash Department of Clinical Epidemiology, Cabrini Hospital, Monash University, Malvern, Australia. rachelle.buchbinder@med.monash.edu.au
Richards
Bethan L
BL
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D018482:Muscle, Skeletal / Q000294:innervation; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D010147:Pain Measurement; D010291:Paresis / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D013716:Tennis Elbow / Q000188:drug therapy*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A